Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Olsson RI"'
Autor:
Narjes F, Llinas A, von Berg S, Jirholt J, Lever S, Pehrson R, Collins M, Malmberg A, Svanberg P, Xue Y; Mechanistic & Structural Biology, Discovery Science, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Olsson RI, Malmberg J, Hughes G, Hossain N, Grindebacke H, Leffler A, Krutrök N, Bäck E, Ramnegård M, Lepistö M, Thunberg L; Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Aagaard A; Mechanistic & Structural Biology, Discovery Science, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., McPheat J; Mechanistic & Structural Biology, Discovery Science, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Hansson EL; Mechanistic & Structural Biology, Discovery Science, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Chen R; Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing 100176, P. R. China., Xiong Y; Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing 100176, P. R. China., Hansson TG
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Sep 23; Vol. 64 (18), pp. 13807-13829. Date of Electronic Publication: 2021 Aug 31.
Autor:
von Berg S; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Xue Y; Structure, Biophysics & FBLG and Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Collins M; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Llinas A; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Olsson RI; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Halvarsson T; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Lindskog M; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Malmberg J; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Jirholt J; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Krutrök N; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Ramnegård M; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Brännström M; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Lundqvist A; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Lepistö M; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Aagaard A; Structure, Biophysics & FBLG and Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., McPheat J; Structure, Biophysics & FBLG and Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Hansson EL; Structure, Biophysics & FBLG and Mechanistic Biology and Profiling, Discovery Sciences, R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Chen R; Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing 100176, P. R. China., Xiong Y; Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing 100176, P. R. China., Hansson TG; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden., Narjes F; Medicinal Chemistry, DMPK, andBioscience, Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2019 May 29; Vol. 10 (6), pp. 972-977. Date of Electronic Publication: 2019 May 29 (Print Publication: 2019).
Autor:
Narjes F, Xue Y, von Berg S, Malmberg J, Llinas A, Olsson RI, Jirholt J, Grindebacke H, Leffler A, Hossain N, Lepistö M, Thunberg L; Early Product Development , Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca , Gothenburg , SE-43183 Mölndal , Sweden., Leek H; Early Product Development , Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca , Gothenburg , SE-43183 Mölndal , Sweden., Aagaard A, McPheat J, Hansson EL, Bäck E, Tångefjord S, Chen R; Pharmaron Beijing Company, Ltd. , Taihe Road , BDA, Beijing 100176 , PR China., Xiong Y; Pharmaron Beijing Company, Ltd. , Taihe Road , BDA, Beijing 100176 , PR China., Hongbin G; Pharmaron Beijing Company, Ltd. , Taihe Road , BDA, Beijing 100176 , PR China., Hansson TG
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2018 Sep 13; Vol. 61 (17), pp. 7796-7813. Date of Electronic Publication: 2018 Aug 27.
Autor:
Ripa L; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Edman K; Discovery Sciences, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 431 83 , Sweden., Dearman M; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Edenro G; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Hendrickx R; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Ullah V; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Chang HF; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Lepistö M; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Chapman D; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Geschwindner S; Discovery Sciences, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 431 83 , Sweden., Wissler L; Discovery Sciences, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 431 83 , Sweden., Svanberg P; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Lawitz K; AstraZeneca R&D Lund , Scheelevägen 1 , Lund 22187 , Sweden., Malmberg J; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Nikitidis A; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Olsson RI; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Bird J; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Llinas A; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Hegelund-Myrbäck T; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden., Berger M; Medicinal Chemistry Berlin, Drug Discovery, Pharmaceuticals , Bayer AG , Berlin 13353 , Germany., Thorne P; AstraZeneca R&D Charnwood , Bakewell Road , Loughborough , Leicestershire LE11 5RH , U.K., Harrison R; AstraZeneca R&D Charnwood , Bakewell Road , Loughborough , Leicestershire LE11 5RH , U.K., Köhler C; Discovery Sciences, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 431 83 , Sweden., Drmota T; Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , Mölndal 43183 , Sweden.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2018 Mar 08; Vol. 61 (5), pp. 1785-1799. Date of Electronic Publication: 2018 Feb 16.
Autor:
Xia L; Division of Medicinal Chemistry, LACDR, Leiden University , 2300RA Leiden, The Netherlands., de Vries H; Division of Medicinal Chemistry, LACDR, Leiden University , 2300RA Leiden, The Netherlands., Lenselink EB; Division of Medicinal Chemistry, LACDR, Leiden University , 2300RA Leiden, The Netherlands., Louvel J; Division of Medicinal Chemistry, LACDR, Leiden University , 2300RA Leiden, The Netherlands., Waring MJ, Cheng L, Pahlén S; Medicinal Chemistry, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca , Gothenburg SE-431 83, Sweden., Petersson MJ; Medicinal Chemistry, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca , Gothenburg SE-431 83, Sweden., Schell P, Olsson RI, Heitman LH; Division of Medicinal Chemistry, LACDR, Leiden University , 2300RA Leiden, The Netherlands., Sheppard RJ; Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca , Cambridge SK10 2NA, United Kingdom., IJzerman AP; Division of Medicinal Chemistry, LACDR, Leiden University , 2300RA Leiden, The Netherlands.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2017 Dec 14; Vol. 60 (23), pp. 9545-9564. Date of Electronic Publication: 2017 Nov 21.
Autor:
Kajanus J; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Jacobson I; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Åstrand A; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Olsson RI; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Gran U; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Björe A; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Fjellström O; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Davidsson Ö; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Emtenäs H; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Dahlén A; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Löfberg B; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Yuan ZQ; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Sundell J; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Cassel J; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Gyll J; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Iliefski T; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Högberg Å; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Lindhardt E; Cardiovascular & Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden., Malmberg J; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, SE-431 83, Sweden.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2016 Apr 15; Vol. 26 (8), pp. 2023-9. Date of Electronic Publication: 2016 Mar 02.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olsson RI; Department of Medicinal Chemistry, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden., Xue Y; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden., von Berg S; Department of Medicinal Chemistry, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden., Aagaard A; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden., McPheat J; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden., Hansson EL; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden., Bernström J; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden., Hansson P; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 43183, Mölndal, Sweden., Jirholt J; Department of Bioscience, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden., Grindebacke H; Department of Bioscience, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden., Leffler A; Department of Bioscience, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden., Chen R; Department of Medicinal Chemistry, Pharmaron Beijing Co., 6 Taihe Road, BDA, Beijing, 10076, P. R. China., Xiong Y; Department of Medicinal Chemistry, Pharmaron Beijing Co., 6 Taihe Road, BDA, Beijing, 10076, P. R. China., Ge H; Department of Medicinal Chemistry, Pharmaron Beijing Co., 6 Taihe Road, BDA, Beijing, 10076, P. R. China., Hansson TG; Department of Medicinal Chemistry, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden., Narjes F; Department of Medicinal Chemistry, AstraZeneca, Respiratory, Inflammation and Autoimmunity iMed, Pepparedsleden 1, 43183, Mölndal, Sweden. Frank.Narjes@astrazeneca.com.
Publikováno v:
ChemMedChem [ChemMedChem] 2016 Jan 19; Vol. 11 (2), pp. 207-16. Date of Electronic Publication: 2015 Nov 10.
Autor:
Olsson RI; Respiratory, Inflammation & Autoimmunity iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden. Electronic address: Roine.I.Olsson@AstraZeneca.com., Jacobson I; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Iliefski T; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Boström J; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Davidsson Ö; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Fjellström O; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Björe A; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Olsson C; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Sundell J; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Gran U; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Gyll J; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Malmberg J; Respiratory, Inflammation & Autoimmunity iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Hidestål O; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Emtenäs H; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Svensson T; Respiratory, Inflammation & Autoimmunity iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Yuan ZQ; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Strandlund G; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Åstrand A; Respiratory, Inflammation & Autoimmunity iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Lindhardt E; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Linhardt G; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Forsström E; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Högberg Å; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Persson F; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Andersson B; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Rönnborg A; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden., Löfberg B; Cardiovascular & Metabolic Diseases iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2014 Mar 01; Vol. 24 (5), pp. 1269-73. Date of Electronic Publication: 2014 Jan 30.
Autor:
Olsson RI; Respiratory & Inflammation iMed, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden. Roine.i.olsson@astrazeneca.com, Jacobson I, Boström J, Fex T, Björe A, Olsson C, Sundell J, Gran U, Öhrn A, Nordin A, Gyll J, Thorstensson M, Hayen A, Aplander K, Hidestål O, Jiang F, Linhardt G, Forsström E, Collins T, Sundqvist M, Lindhardt E, Åstrand A, Löfberg B
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2013 Feb 01; Vol. 23 (3), pp. 706-10. Date of Electronic Publication: 2012 Dec 03.